PetMed Express (PETS) Revenue & Revenue Breakdown
PetMed Express Revenue Highlights
Latest Revenue (Y)
$226.97M
Latest Revenue (Q)
$52.98M
PetMed Express Revenue by Period
PetMed Express Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $226.97M | -19.25% |
| 2024-03-31 | $281.06M | 9.42% |
| 2023-03-31 | $256.86M | -6.06% |
| 2022-03-31 | $273.42M | -9.94% |
| 2021-03-31 | $303.58M | 6.85% |
| 2020-03-31 | $284.13M | 0.25% |
| 2019-03-31 | $283.42M | 3.51% |
| 2018-03-31 | $273.80M | 9.88% |
| 2017-03-31 | $249.18M | 6.18% |
| 2016-03-31 | $234.68M | 2.31% |
| 2015-03-31 | $229.40M | -1.71% |
| 2014-03-31 | $233.39M | 2.44% |
| 2013-03-31 | $227.83M | -4.37% |
| 2012-03-31 | $238.25M | 2.85% |
| 2011-03-31 | $231.64M | -2.78% |
| 2010-03-31 | $238.27M | 8.59% |
| 2009-03-31 | $219.41M | 16.50% |
| 2008-03-31 | $188.34M | 16.08% |
| 2007-03-31 | $162.25M | 17.93% |
| 2006-03-31 | $137.58M | 26.97% |
| 2005-03-31 | $108.36M | 15.28% |
| 2004-03-31 | $93.99M | 70.98% |
| 2003-03-31 | $54.97M | 71.66% |
| 2002-03-31 | $32.03M | 220.06% |
| 2001-03-31 | $10.01M | -31.82% |
| 2000-03-31 | $14.68M | - |
PetMed Express generated $226.97M in revenue during NA 2025, up -19.25% compared to the previous quarter, and up 79.88% compared to the same period a year ago.
PetMed Express Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $52.98M | -11.06% |
| 2024-09-30 | $59.57M | -12.34% |
| 2024-06-30 | $67.95M | 2.18% |
| 2024-03-31 | $66.50M | 1.82% |
| 2023-12-31 | $65.32M | -8.00% |
| 2023-09-30 | $71.00M | -9.26% |
| 2023-06-30 | $78.24M | 25.38% |
| 2023-03-31 | $62.41M | 6.01% |
| 2022-12-31 | $58.87M | -9.98% |
| 2022-09-30 | $65.39M | -6.83% |
| 2022-06-30 | $70.19M | 6.34% |
| 2022-03-31 | $66.00M | 8.70% |
| 2021-12-31 | $60.72M | -9.90% |
| 2021-09-30 | $67.39M | -15.04% |
| 2021-06-30 | $79.31M | 10.65% |
| 2021-03-31 | $71.68M | 8.78% |
| 2020-12-31 | $65.90M | -12.65% |
| 2020-09-30 | $75.44M | -21.59% |
| 2020-06-30 | $96.20M | 29.50% |
| 2020-03-31 | $74.29M | 23.99% |
| 2019-12-31 | $59.91M | -14.33% |
| 2019-09-30 | $69.94M | -12.57% |
| 2019-06-30 | $79.99M | 23.89% |
| 2019-03-31 | $64.56M | 7.49% |
| 2018-12-31 | $60.07M | -15.87% |
| 2018-09-30 | $71.40M | -18.30% |
| 2018-06-30 | $87.39M | 29.81% |
| 2018-03-31 | $67.32M | 12.00% |
| 2017-12-31 | $60.11M | -9.89% |
| 2017-09-30 | $66.71M | -16.25% |
| 2017-06-30 | $79.66M | 26.38% |
| 2017-03-31 | $63.03M | 19.23% |
| 2016-12-31 | $52.87M | -13.04% |
| 2016-09-30 | $60.79M | -16.14% |
| 2016-06-30 | $72.49M | 30.86% |
| 2016-03-31 | $55.39M | 8.75% |
| 2015-12-31 | $50.93M | -10.21% |
| 2015-09-30 | $56.73M | -20.81% |
| 2015-06-30 | $71.63M | 43.29% |
| 2015-03-31 | $49.99M | 1.44% |
| 2014-12-31 | $49.28M | -14.40% |
| 2014-09-30 | $57.58M | -20.63% |
| 2014-06-30 | $72.54M | 49.16% |
| 2014-03-31 | $48.63M | -2.90% |
| 2013-12-31 | $50.09M | -17.18% |
| 2013-09-30 | $60.48M | -18.49% |
| 2013-06-30 | $74.19M | 45.14% |
| 2013-03-31 | $51.12M | 3.05% |
| 2012-12-31 | $49.61M | -14.68% |
| 2012-09-30 | $58.15M | -15.68% |
| 2012-06-30 | $68.95M | 23.30% |
| 2012-03-31 | $55.92M | 10.69% |
| 2011-12-31 | $50.52M | -13.23% |
| 2011-09-30 | $58.23M | -20.87% |
| 2011-06-30 | $73.58M | 44.53% |
| 2011-03-31 | $50.91M | 12.84% |
| 2010-12-31 | $45.12M | -26.33% |
| 2010-09-30 | $61.24M | -17.65% |
| 2010-06-30 | $74.37M | 47.86% |
| 2010-03-31 | $50.30M | 4.02% |
| 2009-12-31 | $48.35M | -22.57% |
| 2009-09-30 | $62.45M | -19.08% |
| 2009-06-30 | $77.17M | 60.53% |
| 2009-03-31 | $48.07M | 10.75% |
| 2008-12-31 | $43.41M | -27.13% |
| 2008-09-30 | $59.57M | -12.87% |
| 2008-06-30 | $68.37M | 69.13% |
| 2008-03-31 | $40.42M | - |
PetMed Express generated $52.98M in revenue during Q3 2025, up -11.06% compared to the previous quarter, and up 74.63% compared to the same period a year ago.
PetMed Express Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PETS | PetMed Express | $226.97M | $52.98M |
| BDSX | Biodesix | $71.32M | $17.96M |
| FBIO | Fortress Biotech | $55.13M | $13.14M |
| SRTS | Sensus Healthcare | $41.81M | $7.32M |
| MRSN | Mersana Therapeutics | $40.50M | $3.06M |
| BDMD | Baird Medical Investment | $31.46M | $6.57M |
| CTSO | Cytosorbents | $25.13M | $8.73M |
| ICCM | IceCure Medical | $3.23M | $736.35K |
| JUNS | Jupiter Neurosciences | - | - |
| TELO | Telomir Pharmaceuticals | - | - |
| TPST | Tempest Therapeutics | - | - |